At a glance
- Originator Aventis
- Class Antiprotozoals
- Mechanism of Action Adenosylmethionine decarboxylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.